Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(3 Reviews)
|
(8 Publications)
Rabbit Recombinant Monoclonal RING2 / RING1B / RNF2 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse samples. Cited in 8 publications.
View Alternative Names
BAP1, DING, HIPI3, RING1B, RNF2, E3 ubiquitin-protein ligase RING2, Huntingtin-interacting protein 2-interacting protein 3, Protein DinG, RING finger protein 1B, RING finger protein 2, RING finger protein BAP-1, RING-type E3 ubiquitin transferase RING2, HIP2-interacting protein 3, RING1b
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (AB181140)
Immunohistochemical analysis of paraffin-embedded Human placenta tissue labeling RING2 / RING1B / RNF2 with ab181140 at 1/500 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (AB181140)
Intracellular Flow Cytometry analysis of HepG2 (human hepatocellular carcinoma) cells labeling RING2 / RING1B / RNF2 with purified ab181140 at 1/70 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (AB181140)
Immunofluorescent analysis of HepG2 cells (paraformaldehyde-fixed 4%) labeling RING2 / RING1B / RNF2 with ab181140 at 1/250 dilution followed by Goat anti rabbit IgG (Alexa Fluor® 555) secondary at 1/200 dilution and counter-stained with DAPI (blue).
- WB
Lab
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (AB181140)
Lanes 1- 2 : Merged signal (red and green). Green - ab181140 observed at 42 kDa. Red - Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) observed at 50 kDa.
ab181140 was shown to react with RING2 / RING1B / RNF2 in wild-type HeLa cells in western blot. The band observed in knockout cell line ab264845 (knockout cell lysate ab257640) lane below 42kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and RNF2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab181140 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (ab181140) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Rnf2 (RING2 / RING1B) knockout HeLa cell lysate at 20 µg
Predicted band size: 37 kDa
Observed band size: 42 kDa
false
- WB
Supplier Data
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (AB181140)
All lanes:
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (ab181140) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
293 cell lysate at 20 µg
Lane 3:
Jurkat cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 37 kDa
false
- WB
Lab
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (AB181140)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : RING2 / RING1B / RNF2 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Jurkat cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab181140 observed at 42 kDa. Red - loading control, ab7291, observed at 52 kDa.
ab181140 was shown to recognize RING2 / RING1B / RNF2 when RING2 / RING1B / RNF2 knockout samples were used, along with additional cross-reactive bands. Wild-type and RING2 / RING1B / RNF2 knockout samples were subjected to SDS-PAGE. ab181140 at a dilution of 1/1000 and ab7291 (loading control to alpha Tubulin) at a dilution of 1/10,000 were incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (ab181140)
Predicted band size: 37 kDa
false
- WB
Lab
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (AB181140)
Lanes 1- 2 : Merged signal (red and green). Green - ab181140 observed at 42 kDa. Red - Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) observed at 50 kDa.
ab181140 was shown to react with RING2 / RING1B / RNF2 in wild-type HeLa cells in western blot. The band observed in CRISPR/Cas9 edited cell line ab264845 (CRISPR/Cas9 edited cell lysate ab257640) lane below 42kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and RNF2 CRISPR/Cas9 edited HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab181140 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RING2 / RING1B / RNF2 antibody [EPR12245] (ab181140) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
RNF2 CRISPR/Cas9 edited HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human RNF2 (RING2 / RING1B) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-rnf2-ring2-ring1b-knockout-hela-cell-line-ab264845'>ab264845</a>)
Predicted band size: 37 kDa
Observed band size: 42 kDa
false
Related conjugates and formulations (10)
-
Anti-RING2 / RING1B / RNF2 antibody [EPR12245] - BSA and Azide free
-
578 PE
PE Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
HRP Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
660 APC
APC Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-RING2 / RING1B / RNF2 antibody [EPR12245]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RING2/RNF2/RING1B regulates gene expression by modifying chromatin structure especially through monoubiquitination of histone H2A at lysine 119. This action occurs within the Polycomb Repressive Complex 1 a multiprotein structure important for maintaining the transcriptional repression of target genes. It influences cell cycle progression and development by silencing genes involved in proliferation and differentiation.
Pathways
RING2/RNF2/RING1B's role connects to the Polycomb group (PcG) pathway and the Wnt signaling pathway. Within these pathways it interacts with proteins like BMI1 and EZH2 which are other components of polycomb complexes. These interactions help modulate chromatin dynamics and control the expression of several genes involved in cell identity and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Cancer & metabolism 12:30 PubMed39456039
2024
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 58:102544 PubMed36427397
2022
Applications
Unspecified application
Species
Unspecified reactive species
The journal of international advanced otology 18:297-301 PubMed35894525
2022
Applications
Unspecified application
Species
Unspecified reactive species
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 33:453-466 PubMed34519833
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 12:610 PubMed34120140
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:2829 PubMed33990559
2021
Applications
Unspecified application
Species
Unspecified reactive species
iScience 24:102435 PubMed34113809
2021
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed31199242
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com